x

Support HDYO

HDYO is the only organization who focus solely on supporting young people impacted by HD around the world. Will you help us?

Donate
x
<span class="translation_missing" title="translation missing: en.hdyo.land.loading">Loading</span>
X
Home Language and Accessibility What is HD? New to HD? Find Resources Research Ask for Help About HDYO News Videos PDF Resources Join Mailing List HDYO Ambassadors Social Media Kids Teens Young Adults Parents and Family JoHD Friends Professionals DONATE! Privacy Contact Us

Update on Ingrezza

May 08, 2024

Huntington's Disease Youth Organization

HDYO has more information about HD available for young people, parents and professionals on our site:

www.hdyo.org

Neurocrine Biosciences is pleased to have received approval from the U.S Food and Drug Administration (FDA) for the new formulation on April 30 – more information can be found in our press release.

The new oral granules formulation provides an alternative administration option for those who have difficulty swallowing or prefer not to swallow whole capsules. We understand that people with HD have a unique set of needs and are pleased that this option will be available for those experiencing chorea.

Neurocrine is in the process of finalizing our launch plans, and we will keep you updated on when the new formulation will become available.

Please let us know if you receive any questions from the community that we can help to address, or you may contact Neurocrine Medical Information (877-641-3461; medinfo@neurocrine.com).

Read full press release

Our content is split into different groups. Choose the group that best describes your needs for more information on HD.

Kids Teens Young Adults Parents and Family JoHD Friends Professionals